Literature DB >> 11139787

Infective Endocarditis.

.   

Abstract

Despite improvements in antibiotic regimens, patients with infective endocarditis (IE) have a high risk of valve replacement and death. Effective initial treatment depends on two steps: 1) diagnosis of the infecting organism, enabling specific antibiotic therapy, and 2) complete characterization of the anatomic extent of infection. Identification of the infecting organism requires culturing of blood prior to the initiation of antibiotics. Whenever possible, at least three sets of blood cultures should be obtained over 6 to 24 hours and held for 4 weeks if necessary to detect unusual or fastidious organisms. Transesophageal echocardiography (TEE) is usually necessary either to confirm the diagnosis or, most importantly, to identify the local complications of infection, many of which mandate surgery. Despite widespread availability, TEE remains under-used, both for the prevention of unnecessary antibiotic therapy in patients at very low risk for the disease and for the recognition of patients likely to benefit from early surgery. The selection of optimal antibiotic therapy depends on microbiologic data to establish the sensitivities of the specific causative organism. Short courses of antibiotic therapy and outpatient administration of intravenous antibiotics are useful in selected cases.

Entities:  

Year:  2001        PMID: 11139787     DOI: 10.1007/s11936-001-0082-x

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  14 in total

Review 1.  Diagnosis and management of infective endocarditis and its complications.

Authors:  A S Bayer; A F Bolger; K A Taubert; W Wilson; J Steckelberg; A W Karchmer; M Levison; H F Chambers; A S Dajani; M H Gewitz; J W Newburger; M A Gerber; S T Shulman; T J Pallasch; T W Gage; P Ferrieri
Journal:  Circulation       Date:  1998 Dec 22-29       Impact factor: 29.690

2.  Mitral valve repair for bacterial endocarditis.

Authors:  W G Hendren; A S Morris; E R Rosenkranz; B W Lytle; P C Taylor; W J Stewart; F D Loop; D M Cosgrove
Journal:  J Thorac Cardiovasc Surg       Date:  1992-01       Impact factor: 5.209

Review 3.  Culture negative endocarditis.

Authors:  P D Barnes; D W Crook
Journal:  J Infect       Date:  1997-11       Impact factor: 6.072

Review 4.  Prevention of bacterial endocarditis. Recommendations by the American Heart Association.

Authors:  A S Dajani; K A Taubert; W Wilson; A F Bolger; A Bayer; P Ferrieri; M H Gewitz; S T Shulman; S Nouri; J W Newburger; C Hutto; T J Pallasch; T W Gage; M E Levison; G Peter; G Zuccaro
Journal:  JAMA       Date:  1997-06-11       Impact factor: 56.272

Review 5.  Infective endocarditis due to unusual or fastidious microorganisms.

Authors:  E F Berbari; F R Cockerill; J M Steckelberg
Journal:  Mayo Clin Proc       Date:  1997-06       Impact factor: 7.616

6.  Transesophageal echocardiographic recognition of subaortic complications in aortic valve endocarditis. Clinical and surgical implications.

Authors:  D G Karalis; R C Bansal; A J Hauck; J J Ross; P M Applegate; K R Jutzy; G S Mintz; K Chandrasekaran
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

7.  Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association.

Authors:  W R Wilson; A W Karchmer; A S Dajani; K A Taubert; A Bayer; D Kaye; A L Bisno; P Ferrieri; S T Shulman; D T Durack
Journal:  JAMA       Date:  1995-12-06       Impact factor: 56.272

Review 8.  Ceftriaxone and outpatient treatment of infective endocarditis.

Authors:  P B Francioli
Journal:  Infect Dis Clin North Am       Date:  1993-03       Impact factor: 5.982

9.  Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis.

Authors:  B K Shively; F T Gurule; C A Roldan; J H Leggett; N B Schiller
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

Review 10.  Infective endocarditis: an analysis based on strict case definitions.

Authors:  C F Von Reyn; B S Levy; R D Arbeit; G Friedland; C S Crumpacker
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.